Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | RDY | SUPN | ||
| Company | Cymabay Therapeutics | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 32.49 | 13.30 | 43.67 | ||
| High | 32.50 | 13.36 | 44.58 | ||
| Low | 32.48 | 13.21 | 43.54 | ||
| Latest | 32.48 | 13.29 | 44.38 | ||
| Change | +0.01 | +0.14 | +0.80 | ||
| % Change | +0.03% | +1.06% | +1.84% | ||
| Volume | 8,356,200 | 2,007,800 | 1,096,000 | ||
| 20-Day Average Volume | 3,390,805 | 1,531,260 | 625,940 | ||
| Previous Close | 32.47 | 13.15 | 43.58 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 13.35 | 45.40 | ||
| 20-Day Raw Stochastic | 94.12% | 37.02% | 26.15% | ||
| 20-Day Relative Strength | 78.00 | 48.41 | 40.78 | ||
| Weighted Alpha | +247.60 | -11.81 | +19.99 | ||
| Today's Opinion | 100% Buy | 96% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -0.52% since 06/11/26 | -2.57% since 06/11/26 | ||
| Low | 32.44 on 03/15/24 | 13.08 on 06/17/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 13.43 on 06/15/26 | 45.71 on 06/12/26 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -2.28% since 05/18/26 | -8.17% since 05/18/26 | ||
| Low | 32.15 on 02/22/24 | 12.95 on 06/03/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 13.86 on 05/26/26 | 49.83 on 05/22/26 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -4.11% since 03/18/26 | -9.96% since 03/18/26 | ||
| Low | 22.11 on 01/26/24 | 12.19 on 05/12/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 14.31 on 03/19/26 | 52.96 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -4.66% since 12/18/25 | -9.94% since 12/18/25 | ||
| Low | 12.32 on 10/13/23 | 12.19 on 05/12/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 14.80 on 02/25/26 | 59.68 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 11,092,472 | 2,575,815 | ||
| Shares Outstanding, K | 114,724 | 834,648 | 58,040 | ||
| Annual Sales | 31,070,000 | 3,580,000,000 | 718,950,000 | ||
| Annual Net Income | -105,370,000 | 456,000,000 | -38,550,000 | ||
| Last Quarter Sales | 60,000 | 593,010,000 | 207,710,000 | ||
| Last Quarter Net Income | -41,900,000 | -10,780,000 | -2,290,000 | ||
| 60-Month Beta | 0.32 | 0.27 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.06 on 05/12/26 | 0.59 on 05/05/26 | ||
| Earnings Date | 05/20/24 | 07/22/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | 0.071 on 07/25/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/24/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.56 | 17.86 | ||